Affinity Asset Advisors, LLC Repare Therapeutics Inc. Transaction History
Affinity Asset Advisors, LLC
- $896 Million
- Q1 2025
A detailed history of Affinity Asset Advisors, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 200,000 shares of RPTX stock, worth $306,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
200,000
Previous 100,000
100.0%
Holding current value
$306,000
Previous $131,000
51.15%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding RPTX
# of Institutions
52Shares Held
30.1MCall Options Held
50KPut Options Held
900-
Bvf Inc San Francisco, CA10.3MShares$15.8 Million0.45% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$5.27 Million1.76% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$5.08 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.54 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.05 Million5.46% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $64.2M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...